In the past decade two new, large federal health insurance programs have been implemented: Medicare’s prescription drug program (Part D) and the Affordable Care Act’s (ACA’s) coverage expansion. The two programs have some similarities but have received very different public and political treatment. Though both were somewhat controversial at time of passage, only the ACA remains as controversial, if not more so, than it was on the day it was signed into law. Is this disparate treatment warranted by the evidence on the merits of the two programs?
To get my take on that question, click over to my post on the JAMA Forum.